{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:02:01Z","timestamp":1785859321811,"version":"3.56.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1097\/01.mbc.0000203862.85610.ac","type":"journal-article","created":{"date-parts":[[2006,2,14]],"date-time":"2006-02-14T04:03:48Z","timestamp":1139889828000},"page":"113-124","source":"Crossref","is-referenced-by-count":21,"title":["High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study"],"prefix":"10.1097","volume":"17","author":[{"given":"Cezary","family":"Watala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Ulicna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Golanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Nocun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iveta","family":"Waczul\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Markuszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zef","family":"Drzewoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210203","doi-asserted-by":"crossref","first-page":"26B","DOI":"10.1016\/0002-9149(93)90142-Y","article-title":"Glycation and oxidation: a role in the pathogenesis of atherosclerosis","volume":"71","author":"Lyons","year":"1993","journal-title":"Am J Cardiol"},{"key":"R2-5-20210203","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/dmrr.233","article-title":"The AGE-receptor in the pathogenesis of diabetic complications","volume":"17","author":"Vlassara","year":"2001","journal-title":"Diabetes Metab Res Rev"},{"key":"R3-5-20210203","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-5793(84)81041-8","article-title":"Nonenzymatic glucosylation of proteins: a new and rapid solution for in vitro investigation","volume":"173","author":"Vaughan","year":"1984","journal-title":"FEBS Lett"},{"key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0968-4328(00)00032-9","article-title":"Collagen as a model system to investigate the use of aspirin as an inhibitor of protein glycation and crosslinking","volume":"32","author":"Hadley","year":"2001","journal-title":"Micron"},{"key":"R5-5-20210203","first-page":"1120","article-title":"Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo","volume":"30","author":"Swamy","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-5-20210203","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0038-1646320","article-title":"Decreased platelet membrane fluidity due to glycation or acetylation of membrane proteins","volume":"68","author":"Winocour","year":"1992","journal-title":"Thromb Haemost"},{"key":"R7-5-20210203","first-page":"286","article-title":"Inhibition of glycation of albumin and hemoglobin by acetylation in vitro and in vivo","volume":"108","author":"Rendell","year":"1986","journal-title":"J Lab Clin Med"},{"key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2003.12.016","article-title":"Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (Aspirin) \u2014 its relation to metabolic control","volume":"113","author":"Watala","year":"2004","journal-title":"Thromb Res"},{"key":"R9-5-20210203","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00109-004-0600-x","article-title":"Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin","volume":"83","author":"Watala","year":"2005","journal-title":"J Mol Med"},{"key":"R10-5-20210203","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.2337\/diacare.26.12.3264","article-title":"Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial","volume":"26","author":"Sacco","year":"2003","journal-title":"Diabetes Care"},{"key":"R11-5-20210203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00592-005-0186-y","article-title":"Prevalence of aspirin resistance in patients with type 2 diabetes","volume":"42","author":"Fateh-Moghadam","year":"2005","journal-title":"Acta Diabetol"},{"key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.diabres.2005.03.033","article-title":"Aspirin sensitivity of platelet aggregation in diabetes mellitus","volume":"70","author":"Albert","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"R13-5-20210203","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1081\/JLC-100102372","article-title":"Selective chemiluminescence analysis of amadori form of glycated human serum albumin","volume":"23","author":"Hanai","year":"2000","journal-title":"J Liq Chrom Rel Technol"},{"key":"R14-5-20210203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0009-8981(83)90078-5","article-title":"Fructosamine: a new approach to the estimation of serum glycosylation. An index of diabetic control","volume":"127","author":"Johnson","year":"1982","journal-title":"Clin Chim Acta"},{"key":"R15-5-20210203","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0003-4975(94)90218-6","article-title":"Relationship of platelet aggregation to bleeding after cardiopulmonary bypass","volume":"57","author":"Ray","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"R16-5-20210203","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0006-2952(01)00777-8","article-title":"Effects of fibrinogen receptor antagonist GR144053F and aurintricarboxylic acid on platelet activation and degranulation","volume":"62","author":"Rozalski","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"R17-5-20210203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0049-3848(03)00238-X","article-title":"Is platelet aggregation a more important contributor than platelet adhesion to the overall platelet-related primary haemostasis measured by PFA-100?","volume":"109","author":"Watala","year":"2003","journal-title":"Thromb Res"},{"key":"R18-5-20210203","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/01.ftd.0000158084.84071.41","article-title":"Resistance to aspirin in patients after coronary artery bypass grafting is transient \u2014 impact on the monitoring of aspirin anti-platelet therapy","volume":"27","author":"Golanski","year":"2005","journal-title":"Therapeut Drug Monit"},{"key":"R19-5-20210203","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00109-002-0386-7","article-title":"Polymorphisms of glycoprotein Ib affect the inhibition by aurintricarboxylic acid of the von Willebrand factor dependent platelet aggregation","volume":"80","author":"Boncler","year":"2002","journal-title":"J Mol Med"},{"key":"R20-5-20210203","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal Biochem"},{"key":"R21-5-20210203","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-1759(94)90081-7","article-title":"Quantitation of epsilon-amino group using amino acids as reference standards by trinitrobenzene sulfonic acid. A simple spectrophotometric method for the estimation of hapten to carrier protein ratio","volume":"167","author":"Sashidhar","year":"1994","journal-title":"J Immunol Methods"},{"key":"R22-5-20210203","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing the difference between two methods of measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"issue":"Suppl 1","key":"R25-5-20210203","first-page":"S72","article-title":"The American Diabetes Association. Aspirin therapy in diabetes","volume":"27","author":"Colwell","year":"2004","journal-title":"Diabetes Care"},{"key":"R26-5-20210203","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/(SICI)1096-9136(199804)15:4<282::AID-DIA591>3.0.CO;2-C","article-title":"Which drugs benefit diabetic patients for secondary prevention of myocardial infarction? DARTS\/MEMO Collaboration","volume":"15","author":"MacDonald","year":"1998","journal-title":"Diabet Med"},{"key":"R27-5-20210203","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"R28-5-20210203","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/01.STR.23.6.851","article-title":"European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke","volume":"23","author":"Sivenius","year":"1992","journal-title":"Stroke"},{"key":"R29-5-20210203","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1345\/aph.1C013","article-title":"Aspirin resistance","volume":"36","author":"Howard","year":"2002","journal-title":"Ann Pharmacother"},{"key":"R30-5-20210203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1023\/A:1015324310374","article-title":"Possible mechanisms of aspirin resistance","volume":"13","author":"Cambria-Kiely","year":"2002","journal-title":"J Thromb Thrombolysis"},{"key":"R31-5-20210203","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.thromres.2004.02.017","article-title":"Aspirin resistance and diabetic angiopathy: back to the future","volume":"113","author":"Di Minno","year":"2004","journal-title":"Thromb Res"},{"key":"R32-5-20210203","first-page":"919","article-title":"Aspirin","author":"Patrono","year":"2002"},{"key":"R33-5-20210203","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1161\/01.CIR.91.11.2819","article-title":"Aspirin enhances the benefits of late reperfusion on infarct shape. A possible mechanism of the beneficial effects of aspirin on survival after acute myocardial infarction","volume":"91","author":"Alhaddad","year":"1995","journal-title":"Circulation"},{"key":"R34-5-20210203","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00501425","article-title":"Effect of acetylsalicylic acid on experimentally induced arterial thrombosis in rats","volume":"301","author":"Meng","year":"1977","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R35-5-20210203","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0160-5402(84)90024-X","article-title":"In vivo study of platelet aggregation in rats","volume":"12","author":"Pinon","year":"1984","journal-title":"J Pharmacol Methods"},{"key":"R36-5-20210203","first-page":"148","article-title":"Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes","volume":"107","author":"Winocour","year":"1986","journal-title":"J Lab Clin Med"},{"key":"R37-5-20210203","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00210-001-0507-9","article-title":"Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy","volume":"365","author":"De la Cruz","year":"2002","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R38-5-20210203","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.2337\/diabetes.54.8.2430","article-title":"Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment","volume":"54","author":"Angiolillo","year":"2005","journal-title":"Diabetes"},{"key":"R39-5-20210203","first-page":"7","article-title":"Platelet function in patients with type 2 diabetes mellitus: the effect of glycaemic control","volume":"10","author":"Davi","year":"1989","journal-title":"Diabetes Res"},{"key":"R40-5-20210203","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199006213222503","article-title":"Thromboxane biosynthesis and platelet function in type II diabetes mellitus","volume":"322","author":"Davi","year":"1990","journal-title":"N Engl J Med"},{"key":"R41-5-20210203","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2337\/diab.41.3.261","article-title":"Differential effect of aspirin on platelet aggregation in IDDM","volume":"41","author":"Mori","year":"1992","journal-title":"Diabetes"},{"key":"R42-5-20210203","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am J Cardiol"},{"key":"R43-5-20210203","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R44-5-20210203","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2337\/diacare.27.5.1244-a","article-title":"Aspirin resistance in diabetic patients","volume":"27","author":"de Gaetano","year":"2004","journal-title":"Diabetes Care"},{"key":"R45-5-20210203","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/labinvest.3780294","article-title":"Immunohistochemical distribution and quantitative biochemical detection of advanced glycation end products in fetal to adult rats and in rats with streptozotocin-induced diabetes","volume":"81","author":"Ling","year":"2001","journal-title":"Lab Invest"},{"key":"R46-5-20210203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2362.1992.tb01930.x","article-title":"Hypersensitivity to ADP of platelets from diabetic rats associated with enhanced fibrinogen binding","volume":"22","author":"Winocour","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"R47-5-20210203","first-page":"100","article-title":"The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide","volume":"6","author":"Judge","year":"1995","journal-title":"J Assoc Acad Minor Phys"},{"key":"R48-5-20210203","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1474-8673.1995.tb00301.x","article-title":"Influence of adrenoceptor stimulation on aggregation of platelets from diabetic and control rats","volume":"15","author":"Austin","year":"1995","journal-title":"J Auton Pharmacol"},{"key":"R49-5-20210203","first-page":"319","article-title":"Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen","volume":"106","author":"Winocour","year":"1985","journal-title":"J Lab Clin Med"},{"key":"R50-5-20210203","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0168-8227(90)90055-X","article-title":"Platelet aggregation and disaggregation in the streptozotocin induced diabetic rat: the effect of sympathetic inhibition","volume":"9","author":"Dunbar","year":"1990","journal-title":"Diabetes Res Clin Pract"},{"key":"R51-5-20210203","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1160\/TH03-02-0097","article-title":"Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy","volume":"90","author":"Ahnadi","year":"2003","journal-title":"Thromb Haemost"},{"key":"R52-5-20210203","first-page":"745","article-title":"Aspirin","author":"Awtry","year":"2002"},{"issue":"Suppl. 1","key":"R53-5-20210203","first-page":"1631","article-title":"Increased aspirin hydrolysis in plasma of patients with type 2 diabetes mellitus: a new mechanism of \u2018aspirin resistance\u2019? [abstract]","volume":"3","author":"Gresner","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R54-5-20210203","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2337\/diacare.27.5.1245","article-title":"Is aspirin resistance a real problem in people with type 2 diabetes?: response to Sacco et al","volume":"27","author":"Drzewoski","year":"2004","journal-title":"Diabetes Care"},{"key":"R55-5-20210203","first-page":"367","article-title":"Aspirin delays thrombin generation in vitro through interaction with platelet phospholipids","volume":"85","author":"Musial","year":"1997","journal-title":"Thromb Res"},{"key":"R56-5-20210203","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.thromres.2003.08.008","article-title":"Aspirin and thrombinogenesis","volume":"110","author":"Szczeklik","year":"2003","journal-title":"Thromb Res"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-200603000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:09:31Z","timestamp":1785856171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200603000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000203862.85610.ac","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}